<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3228">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04337983</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00793-36</org_study_id>
    <nct_id>NCT04337983</nct_id>
  </id_info>
  <brief_title>Hemodynamic Characteristics of Patients With SARS-CoV-2</brief_title>
  <acronym>PiCCOVID</acronym>
  <official_title>Hemodynamic Characteristics of Patients With SARS-CoV-2: PiCCOVID Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bicetre Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bicetre Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
      syndrome coronavirus 2 (SARS-CoV-2) has been declared a public health emergency of
      international concern. Hospitalized COVID-19-positive patients requiring ICU care is
      increasing along with the course of epidemic. A large number of these patients developed
      acute respiratory distress syndrome (ARDS) according to current data. However, the related
      hemodynamic characteristic has so far been rarely described.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The outbreak of COVID-19 is a worldwide concern. To our knowledge, the details of the
      hemodynamic characteristics of COVID-19 patients have not yet been well described. Besides,
      the cardiac injury was reported in about 7-17% of hospitalized patients with COVID-19 in
      previous Chinese publications and is much more common in patients admitted to ICU and
      non-survivors. However, no systematic assessment, including echocardiography evaluating the
      left ventricular function of these patients has been declared. In addition, extravascular
      lung water (EVLW) and pulmonary capillary permeability are two hall markers in ARDS patient's
      management, and transpulmonary thermodilution is a validated method to provide these values
      at the bedside. However, no study has reported the characteristic profile of these variables
      during ARDS caused by SARS-Cov2. A better knowledge of these characteristics would also be
      helpful in guiding their management.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2020</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Body temperature</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Body temperature(°C)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Blood pressure in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse (heart rate)</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Pulse (heart rate) in times/minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Respiratory rate in times/minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data provided by transpulmonary thermodilution-CI</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Cardiac index (L/min/m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data provided by transpulmonary thermodilution-GEDV</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Global end-diastolic volume(mL/m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data provided by transpulmonary thermodilution-EVLW</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Extravascular lung water (mL/kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data provided by transpulmonary thermodilution-PVPI</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Pulmonary vascular permeability index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of abnormal laboratory test results</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of new-onset or reversible systolic left ventricular dysfunction</measure>
    <time_frame>Through study completion, an estimation of 6 months</time_frame>
    <description>Left ventricle ejection fraction, Segmental left ventricle contractility, Speckle tracking data of the left and right ventricles, Dimensions of right and left cavities and Diastolic function of left ventricle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of extravascular lung water measured by transpulmonary thermodilution</measure>
    <time_frame>Change from baseline extravascular lung water at 6 months</time_frame>
    <description>The worst extravascular lung water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of pulmonary vascular permeability index measured by transpulmonary thermodilution</measure>
    <time_frame>Change from baseline extravascular lung water at 6 months</time_frame>
    <description>The worst pulmonary vascular permeability index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between the hemodynamic characteristics and 90-day mortality</measure>
    <time_frame>Up to 90th day after inclusion</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronavirus</condition>
  <condition>SARS-CoV-2</condition>
  <condition>COVID-19</condition>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <condition>Shock</condition>
  <condition>Acute Circulatory Failure</condition>
  <condition>Left Ventricular Dysfunction</condition>
  <condition>Fluid Overload</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transpulmonary thermodilution</intervention_name>
    <description>Obtained by averaging the results of three thermodilution measurements. Each thermodilution is performed by injecting a bolus (15 mL) of cold saline (less than 10°C)</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Daily echocardiography evaluation</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        SARS-Cov2 positive patients admitted to ICU and monitored by transpulmonary thermodilution
        system will be included.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed or suspected SARS-Cov2 cases

          -  Patients admitted to ICU, defined as a unit in which patients can receive
             vasopressors.

          -  Monitored by a transpulmonary thermodilution system (PiCCO2 (Pulsion Medical Systems,
             Feldkirchen, Germany) or EV1000 (Edwards Lifesciences, Irvine, United States of
             America).

        Exclusion Criteria:

          -  SARS Cov-2 Negative

          -  Refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier Monnet, MD.PhD</last_name>
    <phone>+33 01 45 21 35 39</phone>
    <email>xavier.monnet@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bicetre Hospital</name>
      <address>
        <city>Paris</city>
        <state>Val-de-Marne</state>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Monnet, MD. PhD</last_name>
      <phone>331 45 21 35 39</phone>
      <email>xavier.monnet@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.</citation>
    <PMID>32015507</PMID>
  </reference>
  <reference>
    <citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.</citation>
    <PMID>32031570</PMID>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.</citation>
    <PMID>32007143</PMID>
  </reference>
  <reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </reference>
  <reference>
    <citation>Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19. Review.</citation>
    <PMID>32201335</PMID>
  </reference>
  <reference>
    <citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.</citation>
    <PMID>32125452</PMID>
  </reference>
  <reference>
    <citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.</citation>
    <PMID>32105632</PMID>
  </reference>
  <reference>
    <citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.</citation>
    <PMID>32091533</PMID>
  </reference>
  <reference>
    <citation>Schuster DP. The search for &quot;objective&quot; criteria of ARDS. Intensive Care Med. 2007 Mar;33(3):400-2. Epub 2007 Jan 13.</citation>
    <PMID>17221188</PMID>
  </reference>
  <reference>
    <citation>Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013 Feb;41(2):472-80. doi: 10.1097/CCM.0b013e31826ab377.</citation>
    <PMID>23263578</PMID>
  </reference>
  <reference>
    <citation>Monnet X, Teboul JL. Transpulmonary thermodilution: advantages and limits. Crit Care. 2017 Jun 19;21(1):147. doi: 10.1186/s13054-017-1739-5. Review.</citation>
    <PMID>28625165</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bicetre Hospital</investigator_affiliation>
    <investigator_full_name>Xavier Monnet</investigator_full_name>
    <investigator_title>Professor Xavier Monnet MD. PhD.</investigator_title>
  </responsible_party>
  <keyword>Hemodynamic chracteristics</keyword>
  <keyword>Transpulmonary thermodilution</keyword>
  <keyword>Preload-dependency</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Extravascular lung water</keyword>
  <keyword>Pulmonary vascular permeability index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

